Broadfin Capital »

STAAR Surgical Company shares owned by Broadfin Capital

Quarter-by-quarter ownership of STAAR Surgical Company (STAA) shares owned by Broadfin Capital from 13F filings

Historical chart of Broadfin Capital investment in STAAR Surgical Company

Tip: Access up to 7 years of quarterly data

All positions including STAAR Surgical Company held by Broadfin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in STAAR Surgical Company by Broadfin Capital

Quarter filed Position value Share count Share price at filing
2019-12-31 $16M 462k 35.17

More positions owned by Broadfin Capital

Spdr S&p 500 Etf (SPY)
iShares Russell 2000 Index (IWM)
Biohaven Pharmaceutical Holding
SPDR S&P Biotech (XBI)
BioDelivery Sciences International
Alkermes (ALKS)
Viewray (VRAYQ)
Amarin Corporation (AMRN)
Quotient
Eiger Biopharmaceuticals
STAAR Surgical Company (STAA)
Intersect Ent
Progenics Pharmaceuticals
Nanostring Technologies (NSTGQ)
Iovance Biotherapeutics (IOVA)

View all positions for Broadfin Capital

Top funds holding STAAR Surgical Company

Broadwood Capital
BlackRock
Vanguard Group
State Street Corporation
Baillie Gifford & Co
Citadel Advisors
Geode Capital Management
Palo Alto Investors
Millennium Management
Defender Capital
Geneva Capital Management
Dimensional Fund Advisors
Northern Trust
Kayne Anderson Rudnick Investment Management
Ensign Peak Advisors

View all funds holding STAAR Surgical Company